Cargando…

Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial

OBJECTIVE: The aim of this study was to determine whether a Mediterranean‐style, ketogenic diet mobile health application (app) with breath acetone biofeedback is superior to a calorie‐restricted, low‐fat diet app in promoting weight loss. METHODS: Participants (n = 155) with overweight/obesity (mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Falkenhain, Kaja, Locke, Sean R., Lowe, Dylan A., Reitsma, Nicholas J., Lee, Terry, Singer, Joel, Weiss, Ethan J., Little, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518592/
https://www.ncbi.nlm.nih.gov/pubmed/34124856
http://dx.doi.org/10.1002/oby.23242
_version_ 1784584259914170368
author Falkenhain, Kaja
Locke, Sean R.
Lowe, Dylan A.
Reitsma, Nicholas J.
Lee, Terry
Singer, Joel
Weiss, Ethan J.
Little, Jonathan P.
author_facet Falkenhain, Kaja
Locke, Sean R.
Lowe, Dylan A.
Reitsma, Nicholas J.
Lee, Terry
Singer, Joel
Weiss, Ethan J.
Little, Jonathan P.
author_sort Falkenhain, Kaja
collection PubMed
description OBJECTIVE: The aim of this study was to determine whether a Mediterranean‐style, ketogenic diet mobile health application (app) with breath acetone biofeedback is superior to a calorie‐restricted, low‐fat diet app in promoting weight loss. METHODS: Participants (n = 155) with overweight/obesity (mean [SD]: age 41 [11] years, BMI = 34 [5] kg/m(2), 71% female) were randomized to one of the interventions delivered entirely via app. Participants received a wireless scale and were instructed to take daily weight measurements. A third‐party laboratory collected blood samples at baseline and 12 weeks. RESULTS: Weight loss at 12 weeks was greater in the ketogenic (−5.6 kg; 95% CI: −6.7 kg to −4.5 kg) compared with the low‐fat group (−2.5 kg; 95% CI: −3.6 kg to −1.4 kg) (between‐group difference: −3.1 kg; 95% CI: −4.6 kg to −1.5 kg; p < 0.001). Weight loss at 24 weeks indicated durability of the effect (between‐group difference: −5.5 kg; 95% CI: −8.3 kg to −2.8 kg; p < 0.001). Secondary/exploratory outcomes of hemoglobin A1c and liver enzymes were improved to a greater extent in the ketogenic diet group (p < 0.01). CONCLUSIONS: Among adults with overweight/obesity, a ketogenic diet app with breath acetone biofeedback was superior to a calorie‐restricted diet app at promoting weight loss in a real‐world setting.
format Online
Article
Text
id pubmed-8518592
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85185922021-10-21 Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial Falkenhain, Kaja Locke, Sean R. Lowe, Dylan A. Reitsma, Nicholas J. Lee, Terry Singer, Joel Weiss, Ethan J. Little, Jonathan P. Obesity (Silver Spring) ORIGINAL ARTICLES OBJECTIVE: The aim of this study was to determine whether a Mediterranean‐style, ketogenic diet mobile health application (app) with breath acetone biofeedback is superior to a calorie‐restricted, low‐fat diet app in promoting weight loss. METHODS: Participants (n = 155) with overweight/obesity (mean [SD]: age 41 [11] years, BMI = 34 [5] kg/m(2), 71% female) were randomized to one of the interventions delivered entirely via app. Participants received a wireless scale and were instructed to take daily weight measurements. A third‐party laboratory collected blood samples at baseline and 12 weeks. RESULTS: Weight loss at 12 weeks was greater in the ketogenic (−5.6 kg; 95% CI: −6.7 kg to −4.5 kg) compared with the low‐fat group (−2.5 kg; 95% CI: −3.6 kg to −1.4 kg) (between‐group difference: −3.1 kg; 95% CI: −4.6 kg to −1.5 kg; p < 0.001). Weight loss at 24 weeks indicated durability of the effect (between‐group difference: −5.5 kg; 95% CI: −8.3 kg to −2.8 kg; p < 0.001). Secondary/exploratory outcomes of hemoglobin A1c and liver enzymes were improved to a greater extent in the ketogenic diet group (p < 0.01). CONCLUSIONS: Among adults with overweight/obesity, a ketogenic diet app with breath acetone biofeedback was superior to a calorie‐restricted diet app at promoting weight loss in a real‐world setting. John Wiley and Sons Inc. 2021-09-14 2021-10 /pmc/articles/PMC8518592/ /pubmed/34124856 http://dx.doi.org/10.1002/oby.23242 Text en © 2021 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS). https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle ORIGINAL ARTICLES
Falkenhain, Kaja
Locke, Sean R.
Lowe, Dylan A.
Reitsma, Nicholas J.
Lee, Terry
Singer, Joel
Weiss, Ethan J.
Little, Jonathan P.
Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title_full Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title_fullStr Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title_full_unstemmed Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title_short Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
title_sort keyto app and device versus ww app on weight loss and metabolic risk in adults with overweight or obesity: a randomized trial
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518592/
https://www.ncbi.nlm.nih.gov/pubmed/34124856
http://dx.doi.org/10.1002/oby.23242
work_keys_str_mv AT falkenhainkaja keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT lockeseanr keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT lowedylana keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT reitsmanicholasj keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT leeterry keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT singerjoel keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT weissethanj keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial
AT littlejonathanp keytoappanddeviceversuswwapponweightlossandmetabolicriskinadultswithoverweightorobesityarandomizedtrial